
Captor Therapeutics ®
News

May 21, 2025
New Hope in Liver Cancer Treatment – a Clinical Trial of the Innovative Drug CT-01 Has Been Initiated

February 17, 2025
Captor Therapeutics wins prestigious EIC Accelerator recommendation for funding of project CT-03

September 25, 2024
Captor Therapeutics Announces Clinical Candidate for Project CT-03!

August 23, 2024
Captor Therapeutics has applied for approval to conduct a Phase 1 clinical trial in Patients with Hepatocellular Carcinoma

June 12, 2024
Captor Therapeutics has signed an agreement for the implementation and funding of Stage II of the CT-01 Project

May 07, 2024
Captor Therapeutics signed the agreement for II phase implementation and financing for Project CT-03

December 14, 2023
Captor Therapeutics has published financial report for Q1-Q3 2023.

December 14, 2023
Captor Therapeutics has submitted phasing applications to NCBiR for projects CT-01 and CT-03